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Abstract
Background: We have generated gene expression databases for human glial precursors, neuronal
precursors, astrocyte precursors and neural stem cells and focused on comparing the profile of glial
precursors with that of other populations.
Results: A total of 14 samples were analyzed. Each population, previously distinguished from each
other by immunocytochemical analysis of cell surface markers, expressed genes related to their key
differentiation pathways. For the glial precursor cell population, we identified 458 genes that were
uniquely expressed. Expression of a subset of these individual genes was validated by RT-PCR. We
also report genes encoding cell surface markers that may be useful for identification and purification
of human glial precursor populations.
Conclusion: We provide gene expression profile for human glial precursors. Our data suggest
several signaling pathways that are important for proliferation and differentiation of human glial
precursors. Such information may be utilized to further purify glial precursor populations, optimize
media formulation, or study the effects of glial differentiation.
Background
Glial differentiation is a specific developmental process
that has been extensively characterized in both rodents
and human [1]. Embryonic stem cells generate a neuroec-
toderm that undergoes rostrocaudal and dorsoventral pat-
terning and significant expansion to make a large number
of neural stem cells (NSCs). NSCs first generate neuronal
precursors and subsequently differentiate into glial pre-
cursors that further mature into two major types of glia:
oligodendrocytes and astrocytes. During this process,
multiple growth factors, transcription factors and mole-
cules of different signal transduction pathways are
involved, including fibroblast growth factors (FGFs), epi-
dermal growth factors (EGFs), transforming growth fac-
tors beta (TGFβ) family members, Notch-Hes, inhibitor of
DNA-binding (ID) family and Wnt pathways (reviewed in
[2,3]). Identification of these molecules (markers) is
important for the isolation, purification, and characteriza-
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tion of human glial precursors, which may find extensive
applications in transplantation studies and regenerative
medicine.
Studies of glial development and differentiation in rodents
have identified antibodies that recognize markers for isolat-
ing human glial cells [4-7]. For instance, A2B5, which reacts
with ganglioside epitope GT3 [8], characterizes a glial pre-
cursor population [6,7]. Upon further differentiation,
A2B5+ cells give rise to oligodendrocyte precursors that
express PDGFRα, Sox10, and NG2 [2,3]. Multiple lineage
pathways have been suggested for astrocyte development
[9], including maturation of radial glia [10,11], a neuron-
astrocyte precursor and an oligodendrocyte-astrocyte pre-
cursor [7,12-15]. Our laboratory has used antibodies to an
extracellular matrix transmembrane protein CD44 to iso-
late astrocyte precursors from rat, mouse and human neu-
ral tissue. These CD44+ cells only gave rise to astrocytes in
vitro and in vivo and did not differentiate into neuronal or
oligodendrocytic lineages, even in conditions where glial
progenitors or stem cells readily differentiated into such
phenotypes [13]. Growth factors that are important for glial
differentiation include bone morphogenetic proteins
(BMP) 2 and 4, leukemia inhibitory factor (LIF), and ciliary
neurotrophic factor (CNTF, [16-18]).
Although there are significant similarities in the differen-
tiation of glia in chick, rodent and human systems, there
are nevertheless differences as well. For example, A2B5,
which characteristically labels glial precursors in rodent
cells, has been reported to occasionally recognize cells of
the neuronal lineage derived from human embryonic
stem cells (hESCs) [5]. This is not surprising since even
between rat and mouse spinal cord, the A2B5 staining pat-
tern is slightly different (Liu and Rao, unpublished). Like-
wise the pattern of CD44 expression in mouse and rat is
distinct [19,20] and the growth factor requirements of
early precursors appears to differ as well [21].
We have previously created large scale gene expression pro-
files of hESCs, NSCs and multipotent neural precursor cells
and identified a list of markers, which can be used to gener-
ate antibodies, design PCR primers, and characterize devel-
opmental stages for human neural cells [4,22]. In this
manuscript, we extended these studies to compare human
glial progenitors to NSCs and more differentiated progeny.
We confirmed the utility of some of the glial precursor mark-
ers that were defined in rodent, and proposed novel markers
and signaling pathways that may be important for prolifera-
tion and differentiation of human glial precursor cells.
Methods
Preparation of fetal brain derived cell populations
Tissue from fetal cadavers of gestational age 20 to 23
weeks was procured by Procurement Specialists employed
by Advanced Bioscience Resources (ABR) following
Donor ID and Informed Consent SOPs, Donor Medical
Record Review procedures. All protocols and procedures
were reviewed by the Western Institutional Review Board
and deemed that any further IRB oversight was unneces-
sary. Each population of cells included in the present
study was derived from a different biological donor.
The isolation of the cells used in the present study is
described as follows (Figure 1). Fetal forebrain was dissoci-
ated into a single cell suspension using enzymatic and
mechanical methods according to published procedures
and these cells are named as Starting Material: SM [23].
Purified precursors were obtained by single or double
immunomagnetic cell sorting (magnetic cell sorting,
MACS) using Miltenyi superparamagnetic bead technology
according to the manufacturer's instructions. Briefly, the
single cell suspension was incubated in anti-PSA-NCAM
antibody (NCAM; 1:5000, Millipore, MAB5324) followed
by incubation with bead conjugated anti-IgM antibody
(Mitenyi). The NCAM positive cells were purified from the
mixture first by passage through a magnetic field, these cells
were collected and termed NE for NCAM Eluate. Un-
retained cells (NCAM negative, i.e., NCAM flow through)
were collected afterwards and incubated with A2B5 anti-
body (1:1000, R&D Systems, MAB1416) followed by incu-
bation with bead conjugated anti-IgM antibody before they
were passaged through a second magnetic field. Then the
retained cells were collected. These cells were immunologi-
cally NCAM- and A2B5+, and were named NAE, for NCAM
flow through, A2B5 Eluate). AE, another type of population
used in this study was obtained by incubating single cell
suspension with anti-A2B5 antibody followed by bead con-
jugated anti-IgM antibody. The retained cells were A2B5+
and hence named AE (A2B5 Eluate).
Cell Culture
Human fetal tissue derived glial restricted precursor cell
populations (NAE and AE, as described above) were har-
vested and grown on poly-L-ornithine and laminin-coated
dishes for six days in vitro before RNA was extracted for
analysis. Cells were grown in DMEM/F12 (with L-
glutamine and 15 mM Hepes, no phenol red, Invitrogen),
0.01% human serum albumin, 1× N1 supplement (Sigma),
Pen/Strep Fungizone, basic fibroblast growth factor (20 ng/
ml), platelet derived growth factor AA (10 ng/ml), and
Neurotrophin-3 (5 ng/ml). Human astrocyte precursor
cells (hAPCs, CD44+) were derived from human neural
precursor cells (ScienCell Research Laboratories) and cul-
tured as described [20]. Culture of other cell populations
was described in Shin et al [22]. Unpurified cells (SM) and
NCAM+ cells (NE) were not grown in culture and RNA was
extracted shortly after cell purification.
Immunocytochemistry
NAE, NE, AE and SM cells were seeded on chamber slides
(LabTek) and grown overnight before they were fixed withBMC Developmental Biology 2008, 8:102 http://www.biomedcentral.com/1471-213X/8/102
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2% paraformaldehyde. For cell surface antigens, cells were
blocked with detergent free blocking buffer (10% normal
goat serum and 5% bovine serum albumin in PBS) and
for internal antigens Triton X-100 and 0.05% Tween-20
were added to the blocking buffer. The following antibod-
ies were used: A2B5 (1:1000), PSA-NCAM (1:5000),
PDGFRα (BD Pharmingen, 1:200), NG2 (Millipore,
1:200), GFAP (DAKO, 1:4000), Tuj1 (Sigma, 1:4000),
Nestin (BD Bioscience, 1:200) and NeuN (Sigma, 1:200).
Appropriate fluorescent labeled secondary antibodies
(Invitrogen) were used and nuclei were revealed by coun-
ter staining with DAPI.
Illumina bead array, statistical analysis and RT-PCR 
verification
RNA isolation, cDNA synthesis and Illumina bead array
were performed as described [4,24]. Briefly, RNA was iso-
lated from sorted or cultured cells using TRIzol (Invitrogen)
and 100 ng total RNA was used for amplification and
hybridization to Illumina HumanRef-8 BeadChip accord-
ing to the Manufacturer's instructions (Illumina, Inc., San
Diego, CA; http://www.illumina.com/pages.ilmn?ID=197.
Array performed by microarray core facility at the Burnham
Institute for Medical Research). Array data were processed
using Illumina BeadStudio software. Background and rank
invariant method [25,26] were used for normalization. Dif-
ferential gene expression analysis were done using TMEV
program in the TM4 software package [27]. Before analyses,
all populations that have biological or technical replicates
were categorized into six groups, including NAE (A2B5+/
NCAM- double sorted cells, two biological replicates), NE
(NCAM+ single sorted cells, two biological replicates), AE
(A2B5+ single sorted cells, three biological replicates),
hAPC (CD44+ cells, three technical replicates), HOPC
Flow chart of generation of selected samples using MACS or double MACS in this work Figure 1
Flow chart of generation of selected samples using MACS or double MACS in this work.BMC Developmental Biology 2008, 8:102 http://www.biomedcentral.com/1471-213X/8/102
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(A2B5+/NCAM-, fluorescence activated cell sorting, or
FACS-purified cells, two technical replicates), and WBFB
(WB-015 and FB-017, regarded as two biological replicates
of NSCs), and only average values were used for further
analysis along with samples that did not have replicates,
i.e., SM, hAST line and hSC line. Differentially expressed
genes between NAE and NE, AE, WBFB, HOPC and hAPC
samples were identified by t-test [28]. Gene expression lev-
els were considered significant only when their detection
values were ≥ 0.99 (i.e., p-value ≤ 0.01). Selected genes were
verified by RT-PCR using GAPDH as an internal control.
Primer sequences in a 5' to 3' format are presented in
Table 1.
Results
Human glial precursors and neuronal precursors can be 
isolated from fetal tissue
We have established transcriptional profiles of 14 cell
populations derived or purified from human fetal brain
tissues by five different laboratories (Table 2). These
include seven glial precursors derived by two methods,
FACS and MACS; two neuronal precursors, a population
of astrocyte precursors (run in triplicate), an immortalized
human astrocyte line, an immortalized Schwann cell line,
and two populations of NSCs in the form of neurospheres
derived from whole brain and frontal brain. A population
of unsorted fetal brain cells (Starting Material, SM) was
also included as a control. This SM sample showed similar
expression profile to the other seven SM samples exam-
ined in a parallel experiment which will be reported in a
separate manuscript. In the sample list for the current
study, the potential glial precursors NAE (A2B5+/NCAM-
), were obtained from fetal brains of 20 weeks and 21
weeks of age by magnetic bead separation using a double
sorting method. Cells were first incubated with NCAM
antibody, then the NCAM+ population was depleted and
NCAM negative cells collected. After subsequent incuba-
tion with the A2B5 antibody, A2B5+/NCAM- cells were
sorted by magnetic beads. These cells were named NAE
(NCAM depleted, A2B5 column Eluate). FACS-purified
A2B5+/NCAM- cells (HOPC) [22] were included to serve
as a control to the MACS-sorted NAE cell population.
As an assessment of purity, the glial precursor NAE cells
were immunocytochemically characterized. Approxi-
mately 88% of the NAE (A2B5+/NCAM-, MACS sorted)
cell population stained positive for the glial precursor
marker A2B5 (Figure 2B), and ~9% stained positive for
the neuronal precursor marker NCAM (Figure 2D). Com-
pared with the unsorted starting material (SM), cells of
neuronal lineage such as NeuN+ (not shown) or βIII
tubulin (Tuj1)+ cells (Figure 2E) were effectively depleted
in the NAE population. NAE cells expressed several
known glial markers such as GFAP (76%), NG2 (74%),
and PDGFRα (96%, Figure 2C, F, G). These results, com-
bined with the data that were reported for the FACS puri-
fied glial precursors (HOPC, A2B5+/NCAM-), NSCs
(whole brain and forebrain derived neurospheres) [22],
and hAPC (astrocyte precursors, CD44+) [4,20], indicated
that distinct populations of precursors could be isolated
and purified.
We then went on to perform large scale gene expression
profiling using Illumina bead array for all 14 samples
including technical replicates (Table 2). We chose the Illu-
mina array platform because it has been proven to be reli-
able, highly sensitive and cost effective [22,24,29]. This
platform contained ~24,000 transcripts derived from the
Human RefSeq database including full-length and splice
variants. Internal reliability for every transcript was
achieved by averaging signals obtained from ~30 beads
for the same gene or transcript. Before any analysis was
performed, the quality of each sample was evaluated by
two methods; one means was to assess the quality of the
array by analyzing biological or technical replicates in the
same run for their general expression patterns; the other
means was to examine whether known markers that char-
acterized these populations could be detected using the
array system. As shown in Figure 3, biological replicates of
glial precursor populations (NAE) and NSCs (neuro-
spheres) derived from either whole brain (WB) or fore-
brain (FB) were quite similar (R2  = 0.94 and 0.92
respectively; Figure 3A and 3B). Technical replicates for
HOPCs and hAPCs also showed significant overlap (R2 =
0.98 for both; Figure 3C and 3D). Two populations of
neuronal precursors (NE) did not have a high R2 value,
possibly due to the difference in gestational ages or the
nature of the single column purification (data not
shown). In summary, these results show that replicate
samples in the present work cluster closely to each other,
which allows for a robust analysis of the similarities and
differences between these populations.
Based on the properties of this array platform, only when
the detection value is ≥ 0.99 (i.e., detection p value ≤
Table 1: Primers for RT-PCR
Gene Forward primer Reverse primer
C17 cgacttcaacctcctgcagg ttctctggtctcagttcccttagc
CHAD acccagctccacccagcagtg agaacgtcctggcaggtggg
DACH aaaatggtggatctgagggg ttgagtcctcttaggaggcctt
GSTM1 tcaagctatgaggaaaagaagtacacg tcagggagttcctccaagtactttg
MMP7 tacagtgggaacaggctcaggactat gccccacatgtttaaagcctttg
IGSF1 agttctagagttggaggcacca ctgagattcaggctttctccag
LOC150221 attacaaccccctggtgatgtc taaaccatgaccacgtctcctg
PIP3-E gaaagagcatctgaatgcaag tcagcagcagacaaactgttaac
SLC17A8 tgtcaaccacctggacattg tctggacttcacaattctggg
TNFAIP6 gcctattgctacaacccaca caaggtcatgacatttcctgtacBMC Developmental Biology 2008, 8:102 http://www.biomedcentral.com/1471-213X/8/102
Page 5 of 12
(page number not for citation purposes)
0.01), can the corresponding average signal be regarded as
"detected" or "expressed". Generally speaking, when
detection value is ≥ 0.99, the signal intensity value (i.e.,
gene expression level) is almost always ≥ 30. In order to
further restrict the analysis to improve the reliability of the
results, we used a higher cutoff of 100 on signal intensity
values. On average, our cell populations expressed 6,200
to 8,900 transcripts at intensity ≥ 100 (Table 3), which
was similar to the numbers detected in our earlier reports
using Illumina array. Consistent with previous analyses,
genes with the highest abundance were ribosomal and
structural genes (see Additional file 1).
After implementing a signal intensity value cutoff of ≥
100, we next examined the expression of several known
positive and negative glial markers across these samples.
Known glial markers, such as SOX10, PDGFRA, S100B,
NKX2.2, OLIG2, EGFR, NESTIN, and OLIG1, had higher
expression level in glial precursor NAE than in other pop-
ulations (Table 4). In contrast, expression of neuronal lin-
eage-related genes such as NPAS1 (neuronal PAS domain
protein), DCX (doublecortin), CHRNA3 and CHRNA5
(cholinergic receptor nicotinic alpha polypeptide 3 and
5), ENO2 (enolase 2), and NEF3 (neurofilament 3, 150
kDa), was downregulated compared to the unsorted pop-
ulation SM and the sorted neuronal population NE, sup-
porting the conclusion that NAE was a population
enriched for glial precursors but not for neuronal lineage
(Table 5).
Glial precursors show distinct gene expression profiles
Similarities and differences of all samples included in the
present work were determined, with a focus on obtaining
a list of novel glial precursor markers. A Venn diagram
using gene expression intensities of NAE (glial precur-
sors), APC (astrocyte precursors) and SM (unsorted start-
ing material) is shown in Figure 4A. A total of 5,929
transcripts were commonly expressed (at an intensity of ≥
100 in NAE, SM and APC). Four hundred and fifty eight
transcripts were uniquely expressed in the glial precursor
population NAE. Among these 458 transcripts, we vali-
dated 10 by RT-PCR (Figure 4B and 4C), which were
among the 344 genes that were expressed more than two
fold higher in NAE than in other cell types based on the
array data (see Additional file 2).
Novel cell surface markers can be identified for glial 
precursors
In search of novel cell surface markers from A2B5+/
NCAM- magnetically sorted glial precursor NAE cells, we
compared NAE with unsorted fetal brain cells (SM), and
with NCAM+ sorted neuronal precursor NE cells. We
have found that the expression of several known glial
specific cell surface markers, such as NG2 (chondroitin
sulfate proteoglycan 4, melanoma-associated, CSPG4),
was upregulated in NAE. BCAN, the gene encoding the
proteoglycan molecule Brevican,, was found to be
enriched in NAE as its expression was nearly 15-fold
higher in NAE than in unsorted brain cells SM and 2–4
fold higher than in NCAM+ sorted NE and A2B5+ single
sorted AE cells (the signal intensity was 6873.3 in NAE,
466.2 in SM, 2930.8 in NE and 1561.9 in AE). Another
group of cell surface molecules that were differentially
expressed by NAE were members of the integrin family,
particularly integrin beta 5 (ITGB5) and integrin beta 8
(ITGB8). Both were expressed higher (15- and 6-fold,
respectively) in glial precursors than in unpurified cells
(the signal intensity of ITGB5 was 4712.6 in NAE and
301.7 in SM; the signal intensity of ITGB8 was 29.7 in
NAE and 4.9 in SM).
Table 2: Samples included in this study
Bar Code No. Name Description Fetus age Source
1521406071H 1 SM060310 Unsorted fetal brain cells 20 weeks Q therapeutics
1521406071F 2 NAE050421 A2B5+, PSA-NCAM- cells 20 weeks Q therapeutics
1521406071G 3 NAE060615 A2B5+, PSA-NCAM- cells 23 weeks Q therapeutics
1521406071C 4 AE060609–93 A2B5+ cells 21 weeks Q therapeutics
1521406071D 5 AE060617 A2B5+ cells 21 weeks Q therapeutics
1521406071E 6 AE060309 A2B5+ cells 20 weeks Q therapeutics
1521406071A 7 NE060309 PSA-NCAM+ cells 20 weeks Q therapeutics
1521406071B 8 NE060310 PSA-NCAM+ cells 20 weeks Q therapeutics
1334328027F 9 HOPC A2B5+, PSA-NCAM- cells NA Steve Goldman
1334328026C 10 HOPC replicate A2B5+, PSA-NCAM- cells NA Steve Goldman
1400364009C 11 WB-015 Neurosphere from whole brain NA Cognate
1400364009D 12 FB-017 Neurosphere from frontal brain NA Cognate
1400401019A 13 hAPC CD44+ cells 20–22 weeks Mahendra Rao
1334328022D 14 hAPC replicate CD44+ cells 20–22 weeks Mahendra Rao
1334328023C 15 hAPC replicate CD44+ cells 20–22 weeks Mahendra Rao
1400401019B 16 hAST line Human astrocyte line NA Ahmet Hoke
1400401019C 17 hSC line Human Schwann line NA Ahmet HokeBMC Developmental Biology 2008, 8:102 http://www.biomedcentral.com/1471-213X/8/102
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Transcription factors and molecules of major signal 
transduction pathways show distinct profile in A2B5+/
NCAM- glial precursors
Screening of transcription factors, cell surface markers,
receptors, and extracellular matrix molecules showed dis-
tinct profile for glial precursor population NAE. Sixty-one
transcription factors were expressed at 2-fold or higher in
glial precursors NAE, which included known transcription
factors that drove glial specification such as Olig2, ID3
and Nkx2.2. GJA1 (Connexin 43), a known marker for
glial precursors, was detected 4-fold higher in glial precur-
sors (signal intensity 375.3) than in neuronal precursors
(signal intensity 96.2).
We also performed a detailed pathway analysis by com-
paring the A2B5+/NCAM- glial precursors NAE to NSCs
(WBFB, Table 6). Forty seven transcription factors were
expressed higher in NAE than in WBFB. Among them were
genes from the SLIT and NTRK-like family, SLITRK1,
SLITRK4, and SLITRK5, which were expressed 5~10-fold
higher in glial precursor NAE than in WBFB NSCs. In par-
ticular, expression signal value for SLITRK4 in NAE was
160 and was not detected in WBFB (signal intensity<0).
Two secreted frizzled-related proteins, SFRP1 and SFRP2,
which are important antagonists of the Wnt pathway,
were expressed three to five fold higher in the glial precur-
sor NAE. On the contrary, a Wnt inducer, IL11, was also
upregulated in NAE (signal intensity 62.8) and not
detected in NSCs (WBFB, signal intensity <0). These data
indicated that at least Wnt molecules were differentially
regulated in NAE and direct evidence is needed to estab-
lish the role of SFRPs and other Wnt molecules in glial dif-
ferentiation [30-32].
FGFs are important in both proliferation and differentia-
tion of NSCs. Here we have found that FGF9 and FGF12
were highly expressed (3~14-fold) in glial precursors NAE
compared to NSCs WBFB (signal intensity was 58.2 and
116.3 in NAE, and 16.9 and 8 in WBFB). Further examina-
tion of these two growth factors for their role in directing
NSCs or glial precursors toward mature glia is warranted.
Steroids have been shown to affect and regulate glial gene
expression [33]. We have found that corticotropin releas-
ing hormone (CRH or CRF) was highly expressed in NAE
(signal intensity 1989.8) but was 48-fold lower in WBFB
(signal intensity 41.2). Additionally, expression of nuclear
receptor family members such as NR0B1, was upregulated
in NAE as compared to WBFB as well.
Several cell cycle regulators and key genes of the MAPK
pathway, CDKN2B (cyclin-dependent kinase inhibitor
2B, or p15) which inhibits CDK4, and CCNA1 (Cyclin
A1), were found to be expressed at 7–10 fold higher in
NAE than in WBFB.
The TGFβ pathway is a key pathway involved in glial dif-
ferentiation [16,34] and our findings were consistent with
the published data. Expression of several key components
of the TGFβ pathway, for example, nuclear receptor sub-
family 0, group B, member 1 (NR0B1), bone morphoge-
netic protein 6 (BMP6), transforming growth factor beta-
induced (TGFBI), and BMP and activin membrane-bound
inhibitor homolog (BAMBI), was detected more than 10-
fold higher in glial precursor NAE than in NSCs WBFB.
Cyclic AMP also plays an important role in neural and
glial differentiation [35]. Several cAMP related genes,
including calbindin 1 (CALB1), proenkephalin (PENK),
neuropeptide Y (NPY) and secretogranin II (chrom-
ogranin C) (SCG2) were highly expressed in NAE but were
expressed much lower (7~20-fold) or were absent in the
NSC population WBFB.
Discussion
In this manuscript, we generated global gene expression
profiles for human glial precursors, astrocyte precursors,
neuronal precursors and NSCs isolated from fetal tissues
using Illumina bead array. We focused on detailed marker
A2B5+/PSA-NCAM- MACS-sorted cells show properties of  glial precursors Figure 2
A2B5+/PSA-NCAM- MACS-sorted cells show prop-
erties of glial precursors. Immunocytochemistry analysis 
was done for the double MACS-enriched A2B5+/PSA-
NCAM- (NAE) cells. Approximately 87% of NAE cells are 
A2B5+ (B) and ~9% are PSA-NCAM+ (D), They have high 
immunoreactivity to several glial (GFAP; C) and glial precur-
sor markers (NG2 and PDGFRα; F and G). In contrast, 
lower percentage of cells show markers specific for the neu-
ronal lineage, such as PSA-NCAM (D) and TuJ1 (βIII tubulin, 
E).BMC Developmental Biology 2008, 8:102 http://www.biomedcentral.com/1471-213X/8/102
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Scatter plots and dendrogram of related samples Figure 3
Scatter plots and dendrogram of related samples. Biological replicates of MACS sorted glial precursors (NAE) (A), and 
neurospheres (B), and technical replicates of FACS sorted glial precursors (HOPC) (C), and astrocyte precursors (hAPC) (D) 
show high R2 values indicating the array data are reliable. The dendrogram generated using BeadStudio software based on Eucli-
dean distance (E) shows that replicates and samples with similar biological properties cluster closer to each other.BMC Developmental Biology 2008, 8:102 http://www.biomedcentral.com/1471-213X/8/102
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and pathway analysis for glial precursors by comparing
their profile to other populations.
Differential expression of markers on the plasma mem-
brane of glial precursors was used to isolate these cells
from a general population of fetal brain cells. The general
cellular population was depleted for those expressing
NCAM followed by enrichment of those cells that were
recognized by the A2B5 antibody. The resultant popula-
tion (A2B5+ and NCAM-, NAE) has been shown to have
characteristics of glial precursors and give rise to only oli-
godendrocytes and astrocytes upon further differentiation
in vitro and in vivo (Figure 2 and data not shown).
Generally accepted glial precursor markers such as Olig1,
Olig2, Nkx2.2, ID2, ID4, and glutamate transporter genes
were expressed higher in the glial precursor populations
(Table 4, see Additional file 1). Expression data collected
for glial precursors, astrocyte precursors, neuronal precur-
sors, and NSCs showed that glial precursors NAE pos-
sessed a distinct gene expression profile, suggesting
several core signaling pathways that might be important
in glial differentiation. For instance, major components of
the TGFβ pathway, BMP6, BMP7, TGFBI, and TGFBII,
were upregulated in glial precursors when compared to
NSCs or neuronal precursors. These data are consistent
with previous observations that BMPs can induce glial dif-
ferentiation [16-18].
We also found several novel pathways or molecules that
might be involved in glial differentiation. For instance,
the SLIT and NTRK-like family proteins (Slitrk). Slitrk's
are integral membrane proteins, with two leucine-rich
repeat (LRR) domains similar to Slit family and C-term
domains similar to Trk proteins and might possess the Trk
kinase function. Genes of Slitrk family are found to be
predominantly expressed in the brain and glial tumors
including astrocytoma, oligodendroglioma and glioblast-
oma [36]. Consistent with these reports, three Slitrk pro-
teins Slitrk1, Slitrk4 and Slitrk5, as well as Slit2 were
differentially highly expressed in all glial precursor popu-
lations described in this work. These combined indicate
that the Slit pathways are important to glial differentia-
tion. Since Slitrk's are integral transmembrane proteins,
these molecules may also serve as new cell surface markers
for isolating glial precursors.
Similarly, Ephrins, proteins involved in axon guidance,
were found to be differentially expressed in our glial pre-
cursor populations as well. For example, EPHA2, EPHA3,
EPHA5, EPHB6 were expressed 2~4-fold higher in glial
precursors than in NSCs or neuronal populations. In line
with our data, the EphB2 receptor has recently been
reported to be released at the neuron-glia interaction from
neurons and endogenous EphB2 was expressed by glia
simultaneously [37]. In addition, the Ephrin family recep-
tor tyrosine kinases were shown to be upregulated in
response to CNS injury as part of the function of glia [38].
The above mentioned pathways have previously been
implicated in neuronal pathfinding and synaptogenesis.
Their expression in glial lineages may reflect the growing
body of evidence pointing to the importance of glia in
neuronal development events [39,40].
Table 3: Signal abundance of all samples
Samples Signal ≥ 100 %
SM060310 6221 28.0
NAE050421 6453 29.1
NAE060615 7723 34.8
AE060609–93 7807 35.2
AE060617 7491 33.7
AE060309 6649 30.0
NE060309 7242 32.6
NE060310 6908 31.1
HOPC 8016 36.1
HOPC (replicate) 7978 35.9
WB-015 7911 35.6
FB-017 7892 35.5
hAPC 7794 35.1
hAPC (replicate 1) 8901 40.1
hAPC (replicate 2) 8671 39.1
hAST line 7302 32.9
hSC line 8061 36.3
Table 4: Fold change in the expression of selected known glial 
markers in glial precursors NAE versus neuronal precursors NE 
and unsorted population SM
Symbol Synonym NAE/NE NAE/SM
SOX10 DOM;WS4;MGC15649 3.4 19.8
PDGFRA CD140A;PDGFR2 2.9 80.4
S100B NEF;S100 2.8 10.7
NKX2-2 NKX2B;NKX2.2 2.5 22.0
OLIG2 BHLHB1;RACK17;PRKCBP2 2.4 25.5
EGFR ERBB;ERBB1 2.3 40.9
NES FLJ21841 2.0 6.5
OLIG1 BHLHB6 2.0 58.6
Table 5: Expression of neuronal specific genes is downregulated 
in glial precursors NAE versus neuronal precursors NE and 
unsorted population SM
Symbol Synonym NAE/NE NAE/SM
NPAS1 MOP5 0.09 0.06
DCX DC;DBCN;LISX;SCLH;XLIS 0.33 0.31
NEF3 NFM;NEFM;NF-M 0.53 0.82
ENO2 NSE 0.62 0.78
CHRNA5 0.67 0.43
NCAM1 CD56;NCAM;MSK39 0.69 1.87
CHRNA3 0.82 0.61BMC Developmental Biology 2008, 8:102 http://www.biomedcentral.com/1471-213X/8/102
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Differential expression of genes in the Pax-Six-Eya-Dach
(paired box-sine oculis homeobox-eyes absent-dachs-
hund) gene regulatory network was also observed. Dach
was expressed 700 fold higher in glial precursors than
NSCs (Figure 4 and see Additional file 1), and Eya2 and
Six5 were expressed 2~4-fold higher in glial precursors
than in neuronal precursors (see Additional file 1). The
Pax-Six-Eya-Dach network has been shown to be impor-
tant for inner ear and other sensory organ development
[41-44], it may be worthwhile to initiate studies that will
elucidate this pathway's role in glial biology.
Several extracellular matrix metalloproteinases showed dif-
ferential expression in glial populations and other cell
types. For instance, MMP7 was expressed 40- to 200-fold
higher in glial cells than in NSCs (Figure 4 and see Addi-
tional file 1). This is not totally unexpected as MMP7 has
been reported to be involved in the canonical Wnt pathway
as well as during FGF2-mediated response [45]. Expression
of another metalloproteinase related molecule, tissue
inhibitor of metalloproteinase 3 (TIMP3), was elevated in
glial precursors as well (the signal intensity in NAE was
496.7). These data indicate that the metalloproteinase fam-
ily may actively participate in glial differentiation.
Several frizzled-related protein molecules of the Wnt
pathway, SFRP1, SFRP2 FRPB, IL11, and FRAT1, were
highly expressed in glial precursors when compared to
NSCs. However, similar expression was detected for these
Wnt molecules in neuronal precursors, supporting the
conclusion that these proteins are involved in general
neural cell differentiation instead of glial specification.
Another gene that was brought to our attention was PENK
(proenkephalin). It was expressed higher in glial precur-
sors NAE and HOPC (signal intensities 400–3000) but
was not detected in NSCs (signal intensity <0, Additional
file 1). However, when we examined the expression levels
of MAPK1 and MAPK3 (p38), major components of the
MAPK-ERK pathway, which regulates PENK expression,
no significant changes were found. Possible reasons might
be that phosphorylation status or other posttranslational
modifications are more important in determining the
pathway activity than mRNA levels. To confirm this, pro-
teomic analysis needs to be done as we and others have
performed for several cell types including hESCs [46]. This
is worth mentioning as protein expression and function
are regulated at multiple levels while the present work
focuses on the mRNA levels only.
Genes relevant to the signal transduction pathways Akt,
CNTF, SDF-1/CXCR4, PDGF, glial cell line-derived nerve
growth factor (GDNF) and receptor tyrosine kinase (RTK)
were found to be differentially expressed as well. As
expected, members of the PDGF pathway were expressed
higher in glial precursors. For the EGF receptor family,
NRG1 and EGFR, ERBB3, and the downstream effector
SOS were also observed to be differentially upregulated in
glial populations as compared to NSCs and neuronal pre-
cursors.
Recently, several zinc finger proteins have been implicated
in various processes of neural development and glial dif-
ferentiation [47,48]. Here we have found that zinc finger
proteins Znf135, Znf136, Znf161, Znf24, Znf91, Znf435,
Znf154, Znf232, and Znf219, were expressed as much as
14-fold or higher in glial precursors than in astrocyte pre-
cursors hAPC. Znf494, a zinc finger protein of unknown
function [49] was expressed 415~663-fold higher in glial
precursors than in NSCs. Conversely, another set of zinc
finger proteins, Znf145, Znf537 Znf345, Znf370, Znf51
(Bcl6), Znf268, Znf375, and Znf373, were highly
expressed in hAPC. The zinc fingers identified in this work
may warrant further study.
Analyses of these expression data have led to the identifi-
cation of novel cell surface markers which may be used for
Unique genes that are expressed in glial precursors NAE Figure 4
Unique genes that are expressed in glial precursors 
NAE. (A) shows the extent of overlap for expressed genes 
of three distinct types of cell populations, NAE, unsorted SM 
and astrocyte precursor hAPC. A total of 458 transcripts are 
expressed at ≥ 100 as detected by the array uniquely to NAE 
(detailed gene list can be found in Additional file 2). A 
selected group of genes (B) are validated by RT-PCR (C). In 
(B), the numbers in columns NAE, SM and APC represent 
the expression levels of these samples. The units are arbi-
trary as the signals are obtained by comparing with the back-
ground signals of the array chip. The numbers in columns 
NAE/SM and NAE/APC represent the ratios of the expres-
sion levels of the listed genes. The RT-PCR results (C) vali-
date that all 10 genes listed in (B) have higher expression for 
NAE than for SM or APC, while the expression for the inter-
nal control GAPDH is similar across all three samples.BMC Developmental Biology 2008, 8:102 http://www.biomedcentral.com/1471-213X/8/102
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identification or isolation of glial precursors. Our results
indicate that in addition to the well accepted surface
marker NG2, Brevican and Integrin beta 5 and beta 8 are
potential cell surface molecules for glial precursors. Brevi-
can is a neural-specific chondroitin sulfate proteoglycan
and is expressed in mature astrocytes and downregulated
in adult rat spinal cords [50,51]. β integrins have been
reported to be involved in spinal cord injury and regener-
ation process. Both Brevican and integrins can be regu-
lated by the TGFβ pathway [50,52]. Our results show that
Brevican expression is significantly increased in glial pre-
cursors. In line with this, expression of ADAMTS4, a gene
that encodes a disintegrin and metalloproteinase that
selectively cleaves Brevican/Lectican, also is elevated in
the glial precursor population. A detailed time course
study of its expression in glial development in the human
fetal brain is underway to validate its utility as a marker for
isolating glial precursors.
Conclusion
We have compared gene expression profile of glial precur-
sors to neuronal precursors, astrocyte precursors and
NSCs. Such information may be utilized to further purify
glial precursor populations, optimize media formulation,
or study the effects of glial cell differentiation.
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